Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-25-002888
Filing Date
2025-03-17
Accepted
2025-03-17 16:20:10
Documents
41
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pbsv_10q.htm   iXBRL 10-Q 581540
2 CERTIFICATION pbsv_ex311.htm EX-31.1 11852
3 CERTIFICATION pbsv_ex312.htm EX-31.2 9968
4 CERTIFICATION pbsv_ex321.htm EX-32.1 3742
  Complete submission text file 0001654954-25-002888.txt   2637757

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pbsv-20250131.xsd EX-101.SCH 21764
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pbsv-20250131_lab.xml EX-101.LAB 154694
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pbsv-20250131_cal.xml EX-101.CAL 33695
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pbsv-20250131_pre.xml EX-101.PRE 119304
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pbsv-20250131_def.xml EX-101.DEF 41508
44 EXTRACTED XBRL INSTANCE DOCUMENT pbsv_10q_htm.xml XML 311287
Mailing Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646
Business Address INDUSTRIAL ZONE STREET 1 LOT 14 DORADO PR 00646 787-278-2709
Pharma-Bio Serv, Inc. (Filer) CIK: 0001304161 (see all company filings)

EIN.: 200653570 | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-50956 | Film No.: 25744758
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)